Bob Mischler is our Senior Vice President, New Product Planning and Strategy, and has been with Acadia since March 2015.
Mr. Mischler’s previous role at Acadia was Senior Vice President, Strategy and Technology Operations, where he was responsible for manufacturing, quality assurance and pharmaceutical development.
Prior to joining Acadia, Mr. Mischler served as Vice President, Scientific Affairs and Business Development at Ardea Biosciences, a member of the AstraZeneca Group, where he led the development and implementation of its lifecycle management strategy for the global gout franchise. Previously, he served as Vice President, Commercial Planning and Analytics at Ardea Biosciences, where he was significantly involved in business development and led commercial activities.
Earlier in his career, he worked in various roles focused on product and portfolio strategy at CovX Research LLC, Pfizer Inc. and Eli Lilly and Company. Mr. Mischler received a B.S. in Biologic Sciences from Indiana University and an M.B.A. from the UCLA Anderson School of Management.